| Q38281657 | Adult liver disorders caused by inborn errors of metabolism: review and update |
| Q77872061 | Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice |
| Q41706847 | Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives |
| Q35782589 | Chronic iron overload in rats induces oval cells in the liver. |
| Q77803135 | Clinical management of iron overload |
| Q26775055 | Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects |
| Q34588158 | Diffuse liver disease |
| Q36883885 | Early genes induced in hepatic stellate cells during wound healing |
| Q34563350 | Epidemiology of primary and secondary liver cancers |
| Q53449416 | Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. |
| Q40432337 | GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. |
| Q40744618 | Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma |
| Q77798384 | Haemochromatosis |
| Q73571411 | Hemochromatosis |
| Q34661782 | Hepatic iron overload and hepatocellular carcinoma |
| Q40645871 | Hepatic neoformations |
| Q40408295 | Hepatic neoplasia: reflections and ruminations |
| Q34170405 | Hepatocellular cancer. A century of progress |
| Q34037556 | Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis |
| Q78129568 | Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report |
| Q73650890 | Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis |
| Q33866448 | Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations |
| Q58416352 | Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver |
| Q34756070 | Hepatocellular carcinoma: predisposing conditions and precursor lesions |
| Q35777612 | Hereditary haemochromatosis |
| Q33927510 | Hereditary hemochromatosis |
| Q43044191 | Incidence of hepatocellular carcinoma in a thalassemia unit |
| Q73876513 | Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver |
| Q71958739 | Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver |
| Q39180946 | Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines |
| Q34249712 | Iron and hepatocellular carcinoma |
| Q35212536 | Iron and liver cancer |
| Q41758982 | Iron and neoplasia |
| Q53445682 | Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate. |
| Q77133998 | Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox |
| Q34746229 | Iron overload disorders |
| Q36814306 | Iron overload syndromes and the liver |
| Q84410009 | Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report |
| Q32059980 | Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies |
| Q34544259 | MR imaging in chronic hepatitis and cirrhosis |
| Q41721368 | Magnetic resonance imaging of focal and diffuse hepatic disease |
| Q42140353 | Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment |
| Q26749329 | New advances in hepatocellular carcinoma |
| Q77350070 | Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis |
| Q80868194 | Pathology of hepatic iron overload |
| Q40966808 | Pediatric gastroenterology. Update on metabolic liver disease |
| Q53425799 | Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. |
| Q72658678 | Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients |
| Q73292350 | Primary hepatocellular carcinoma in workers exposed to vinyl chloride: a report of two cases |
| Q62607309 | Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis |
| Q33274401 | Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle |
| Q64115461 | Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment |
| Q50106577 | Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases |
| Q43586170 | Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis |
| Q37570855 | Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients |
| Q73692687 | Stearoyl coenzyme A desaturase 1 expression and activity are increased in the liver during iron overload |
| Q73740633 | Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis |
| Q72511357 | The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis |
| Q73208505 | The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver |
| Q92005158 | The risk of liver cancer in autoimmune liver diseases |
| Q77589677 | [Hereditary hemochromatosis: physiopathological, clinical and therapeutical considerations] |
| Q53526177 | [Should we screen for hepatocellular carcinoma?]. |